European CHMP Adopts Positive Opinion for Gileads Vemlidy Tenofovir Alafenamide TAF for the Treatment of Chronic Hepatitis B Virus Infection

Friday November 11th 2016 at 1225pm UTC &8212; Vemlidy Demonstrated Similar Efficacy with Improvements in Renal and Bone Laboratory Safety Parameters Compared to Viread in Phase 3 Studies &821…
Read the full story: Bioportfolio Latest News